Target Name: CAPN13
NCBI ID: G92291
Other Name(s): calpain 13 | CANP 13 | CAN13_HUMAN | calcium-activated neutral proteinase 13 | Calpain 13 | Calcium-activated neutral proteinase 13 | Calpain-13

Unlocking The Potential of CAPN13: A Protein Involved in Pain and Inflammation

CAPN13, or calpain 13, is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and heart. It is a member of the calpain family of proteins, which are involved in the regulation of pain signaling. Calpain 13 is unique among its family members due to its unique structure and function.

One of the key features of CAPN13 is its ability to interact with other proteins, particularly with the protein known as calpastatin. Calpastatin is a natural compound that is found in various tissues throughout the body, including the pancreas, where it plays a role in the regulation of insulin secretion. Calpastatin is also known as 2-phenyl-1-propanethial-1-one (2-Pp-PG), and it is a potent inhibitor of the enzyme calcineurin, which is involved in the regulation of many physiological processes in the body.

CAPN13 and calpastatin have been shown to have a strong positive correlation, and high levels of CAPN13 have been linked to decreased levels of calpastatin. This suggests that CAPN13 may be a useful biomarker for tracking the effectiveness of treatments that are designed to increase levels of calpastatin. Additionally, the fact that CAPN13 is expressed in the brain suggests that it may be involved in the regulation of pain signaling in this organ.

Another interesting feature of CAPN13 is its ability to interact with the protein known as TrPV4. TrPV4 is a receptor that is involved in the regulation of pain signaling in the body, and it is expressed in various tissues throughout the body, including the brain. CAPN13 has been shown to interact with TrPV4 in a number of ways, including through the regulation of TrPV4 function and the modulation of pain signaling.

CAPN13 has also been shown to play a role in the regulation of the production of reactive oxygen species (ROS), which are free radicals that can cause damage to tissues and contribute to the development of a variety of diseases. ROS are produced naturally by the body and can be generated by a variety of factors, including exercise, stress, and inflammation. CAPN13 has been shown to be involved in the regulation of ROS production and the modulation of ROS levels in various tissues.

In addition to its potential role in the regulation of pain and inflammation, CAPN13 is also of interest as a potential drug target. The calpain family of proteins has been shown to be involved in a wide range of physiological processes, including the regulation of pain signaling, inflammation, and cellular signaling. As such, CAPN13 may be a useful target for the development of new drugs that are designed to modulate these processes. Additionally, the fact that CAPN13 is expressed in various tissues throughout the body suggests that it may be a useful target for the development of drugs that are designed to affect a wide range of physiological processes.

In conclusion, CAPN13 is a unique and fascinating protein that is involved in a wide range of physiological processes throughout the body. Its ability to interact with other proteins, including calpastatin and TrPV4, suggests that it may be a useful biomarker for tracking the effectiveness of treatments that are designed to increase levels of these proteins. Additionally, the fact that CAPN13 is expressed in the brain and is involved in the regulation of pain signaling suggests that it may be involved in the development and progression of a wide range of diseases. The potential drug target that CAPN13 represents makes it an attractive target for the development of new treatments that are designed to modulate these processes.

Protein Name: Calpain 13

Functions: Probable non-lysosomal thiol-protease

More Common Targets

CAPN14 | CAPN15 | CAPN2 | CAPN3 | CAPN5 | CAPN6 | CAPN7 | CAPN8 | CAPN9 | CAPNS1 | CAPNS2 | CAPRIN1 | CAPRIN2 | CAPS | CAPS2 | CAPSL | CAPZA1 | CAPZA2 | CAPZA3 | CAPZB | Carbonic Anhydrase | Carbonic Anhydrase V | Carboxylesterase | Carboxypeptidase A | Carboxypeptidase B | Carboxypeptidase N | Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEA) | CARD10 | CARD11 | CARD14 | CARD16 | CARD17P | CARD18 | CARD19 | CARD6 | CARD8 | CARD8-AS1 | CARD9 | Cardiac Troponin | CARF | CARHSP1 | CARM1 | CARMAL | CARMIL1 | CARMIL2 | CARMIL3 | CARMN | Carnitine O-Palmitoyltransferase (CPT) | Carnitine O-Palmitoyltransferase 1 (CPT-1) | Carnitine O-palmitoyltransferase 2 | CARNMT1 | CARNS1 | CARS1 | CARS1-AS1 | CARS2 | CARTPT | CASC11 | CASC15 | CASC16 | CASC17 | CASC18 | CASC19 | CASC2 | CASC20 | CASC21 | CASC22 | CASC3 | CASC6 | CASC8 | CASC9 | CASD1 | Casein Kinase | Casein kinase I | Casein Kinase I gamma | Casein kinase II (CKII) | CASK | CASKIN1 | CASKIN2 | CASKP1 | CASP1 | CASP10 | CASP12 | CASP14 | CASP16P | CASP1P2 | CASP2 | CASP3 | CASP4 | CASP4LP | CASP5 | CASP6 | CASP7 | CASP8 | CASP8AP2 | CASP9 | Caspase | CASQ1 | CASQ2 | CASR | CASS4